Cell and gene therapy supply chains have dealt with significant impacts from the COVID-19 pandemic, leading to questions of shipping efficiency, transparency and certainty.
In the latest Insight from Biocair you will learn about:
- How COVID-19 has impacted the cell and gene therapy supply chain management
- How to deal with the airfreight shortage
- The role of packaging for an unbroken cold chain